Results 51 to 60 of about 1,251,690 (298)

National mass drug administration costs for lymphatic filariasis elimination. [PDF]

PLoS Neglected Tropical Diseases, 2007
BACKGROUND: Because lymphatic filariasis (LF) elimination efforts are hampered by a dearth of economic information about the cost of mass drug administration (MDA) programs (using either albendazole with diethylcarbamazine [DEC] or albendazole with ...
Ann S Goldman, Victoria H Guisinger, Moses Aikins, Maria Lourdes E Amarillo, Vicente Y Belizario, Bertha Garshong, John Gyapong, Conrad Kabali, Hussein A Kamal, Sanjat Kanjilal, Dominique Kyelem, Jefrey Lizardo, Mwele Malecela, Godfrey Mubyazi, P Abdoulaye Nitièma, Reda M R Ramzy, Thomas G Streit, Aaron Wallace, Molly A Brady, Richard Rheingans, Eric A Ottesen, Anne C Haddix   +21 more
doaj   +1 more source

Predictive Probabilities In Employee Drug-Testing [PDF]

, 1991
Substance abuse in the U.S. has been estimated to cost $99 billion annually through lower productivity. Yet the authors urge caution in attempting to reduce these costs and health and safety Risks.
Barnum, Darold T., Gleason, John M.
core   +2 more sources

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Promoting adverse drug reaction reporting: comparison of different approaches

Revista de Saúde Pública, 2016
OBJECTIVE To describe different approaches to promote adverse drug reaction reporting among health care professionals, determining their cost-effectiveness.
Inês Ribeiro-Vaz, Cristina Costa Santos, Ricardo Cruz-Correia   +2 more
doaj   +1 more source

Costs of mass drug administration for scabies in Fiji.

PLoS Neglected Tropical Diseases, 2022
In 2019, the Murdoch Children's Research Institute in partnership with the Fiji Ministry of Health and Medical Services carried out an integrated mass drug administration (MDA) for the treatment of scabies and lymphatic filariasis in the Northern ...
Maria Mow, Li Jun Thean, Matthew Parnaby, Jyotishna Mani, Eric Rafai, Aalisha Sahukhan, Mike Kama, Meciusela Tuicakau, Joseph Kado, Lucia Romani, Daniel Engelman, Margot Whitfeld, John Kaldor, Andrew Steer, Natalie Carvalho   +14 more
doaj   +1 more source

Differential regulation of ZFAS1 splice variants by endoplasmic reticulum stress in hepatocyte cell lines

FEBS Open Bio, EarlyView.
ZFAS1 is a lncRNA promoting cell proliferation and migration, exhibiting high expression in various cancers. It is conserved, widely expressed, and produces multiple splice variants with unclear roles. We identified several splice variants in hepatocyte models, and found that inhibiting or suppressing regulators of the unfolded protein response (PERK ...
Sébastien Soubeyrand, Paulina Lau, Ruth McPherson   +2 more
wiley   +1 more source

Economic implications of the different statin prescribing patterns in Central Portugal: a longitudinal analysis

Journal of Pharmaceutical Policy and Practice
Background Statins are one of the most widely used therapeutic classes and have significantly contributed to health care expenditures with reported variability between countries and regions.
Catarina Abrantes, Luciana G. Negrão, Catarina Coelho, M. Margarida Castel-Branco, Isabel V. Figueiredo, Fernando Fernandez-Llimos   +5 more
doaj   +1 more source

Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults. [PDF]

, 2019
Adverse drug reactions (ADRs) contribute to hospitalization but data on its economic burden is scant. Pre-emptive pharmacogenetic (PGx) testing can potentially reduce ADRs and its associated costs.
Brunham, Liam R, Chan, Alexandre, Chan, Sze Ling, Ng, Hong Yen, Sung, Cynthia, Wee, Hwee-Lin, Winther, Michael D   +6 more
core   +1 more source

Establishing an assay to evaluate d‐amino acid oxidase enzyme kinetics and inhibition using WST‐8 redox dye

FEBS Open Bio, EarlyView.
This study investigated a novel WST‐8‐based assay for evaluating d‐Amino acid oxidase (DAO) inhibitors. We confirmed its effectiveness using known inhibitors and found that uremic toxins possess relatively weak inhibitory activity compared to existing drugs.
Kahoko Miyake, Yuki Enoki, Yuka Nakazawa, Kazuaki Taguchi, Kazuaki Matsumoto   +4 more
wiley   +1 more source

Consumer-Directed Health Care: Can Consumers Look After Themselves? [PDF]

, 2008
In health care systems today, including those of Switzerland and the United States, participants do not necessarily see the big picture of lifetime health costs and quality of life, and in many systems consumers and providers lack the incentives to ...
Heiss, Florian, McFadden, Daniel, Winter, Joachim   +2 more
core   +2 more sources